StonvexLoading…
StonvexStonvexStonvexCore line items from RKDA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.10M | $4.86M | $3.96M | $2.65M |
Operating Income | $-779.00K | $-2.50M | $-1.13M | $29.00K |
Net Income | $-4.38M | $-2.34M | $-1.00M | $-1.86M |
EPS (Diluted) | $-2.11 | $-1.71 | $-0.73 | $-1.36 |
Total Assets | $5.32M | $6.55M | $8.58M | $7.79M |
Total Liabilities | $2.44M | $2.41M | $3.14M | $3.25M |
Cash & Equivalents | $954.00K | $259.00K | $1.12M | $1.38M |
Free Cash Flow OCF − CapEx | Not available | $-4.70M | $-3.88M | $-3.62M |
Shares Outstanding | 2.06M | 1.37M | 1.37M | 1.37M |